Genelife Clinical Research is a technologically advanced CRO that aims to reduce drug development timelines through high quality services. It provides comprehensive clinical trial services from early phase to late phase trials across multiple therapeutic areas globally. Genelife utilizes experienced professionals and innovative tools to efficiently manage projects and ensure quality and regulatory compliance. Its goal is to become the most respected partner in providing product development and meeting unmet clinical research needs.
As an expert provider of a wide spectrum of clinical development support services, KCR has developed
a supreme Data Management (DM) solution geared towards full data transparency as well as
delivering the highest level of quality within the defined timelines and in adherence to study budgets,
all the while ensuring the meeting of all Good Clinical Practice (GCP) and ICH requirements. Read our DM brochure and learn more about KCR DM capabilities.
The Risk-Based Monitoring (RBM) discussion is moving away from one focused on changing monitoring methods and reducing source document verification (SDV) to 'intelligent monitoring.' Learn why here!
Healthcare Delivery Reimagined: Patient Flow and Care Coordination AnalyticsAdrish Sannyasi
Come to learn how Splunk’s data analytics platform could be utilized to solve many high impact business problems in healthcare delivery systems to reduce cost, improve patient outcome and safety, and enhance care coordination experience. Analyze observed behavior from healthcare event data and metadata to discover patterns, monitor compliance, and optimize the workflow. Furthermore 80% of healthcare data is unstructured (clinical free text and documentation), or semi-structured and many new data sources are such as tele health, mobile health, sensors, and devices are getting integrated in many healthcare systems specifically in the area of chronic disease management. So, one need analytics software that can harvest, interpret, enrich, normalize, and model diverse structured and unstructured data and analytics approaches that embrace the “data turmoil” by relying less on standardized data items and more on the capability to process data in any format.
As an expert provider of a wide spectrum of clinical development support services, KCR has developed
a supreme Data Management (DM) solution geared towards full data transparency as well as
delivering the highest level of quality within the defined timelines and in adherence to study budgets,
all the while ensuring the meeting of all Good Clinical Practice (GCP) and ICH requirements. Read our DM brochure and learn more about KCR DM capabilities.
The Risk-Based Monitoring (RBM) discussion is moving away from one focused on changing monitoring methods and reducing source document verification (SDV) to 'intelligent monitoring.' Learn why here!
Healthcare Delivery Reimagined: Patient Flow and Care Coordination AnalyticsAdrish Sannyasi
Come to learn how Splunk’s data analytics platform could be utilized to solve many high impact business problems in healthcare delivery systems to reduce cost, improve patient outcome and safety, and enhance care coordination experience. Analyze observed behavior from healthcare event data and metadata to discover patterns, monitor compliance, and optimize the workflow. Furthermore 80% of healthcare data is unstructured (clinical free text and documentation), or semi-structured and many new data sources are such as tele health, mobile health, sensors, and devices are getting integrated in many healthcare systems specifically in the area of chronic disease management. So, one need analytics software that can harvest, interpret, enrich, normalize, and model diverse structured and unstructured data and analytics approaches that embrace the “data turmoil” by relying less on standardized data items and more on the capability to process data in any format.
IDSC is an interdisciplinary group of 40 ex-pharma leaders averaging 25-years of big-pharma, biotech, and academic experience. Our clients come to us for drug discovery and drug development interim leadership, consulting, fully integrated collaborations, due diligence, molecular modeling, and outsourcing management. Because we are a fully integrated drug discovery, preclinical development, and clinical development partner, we help our biotech, VC, academic, and pharma clients get from early discovery to IND filing and through phase I clinical trials in all major therapeutic areas and on to NDA in antibacterials, CNS, and oncology.
This Risk Based Monitoring - Impact on Sites overview presentation, on targeted topics, was delivered to the ACRP Raleigh - Durham Chapter's Annual Conference in 2013.
Strategic Consulting Partners in Life Science for a High Performing Paperless Lab
- Do you need to increase productivity and effectiveness of your lab operations?
- Do you want to reduce time to market and boost collaboration ?
- Are you concerned about data quality / data integrity issues?
- Do you need to replace your lab informatics systems and feel overwhelmed by the complexity of the market?
- Do you need to align consistent processes throughout the organisation?
With our success-proven seven-step program we have realized up to 30% efficiency improvements for major European Life Science companies lab operations.
We are lab-experienced chemists with a solid background in business administration and management, a passion for sustainable process improvements and in-depth knowledge of lab informatics. Originating from the renowned "Vialis paperless lab solutions" team, PEPR-Consulting continues its tradition of successful strategic management consulting for the life science industry.
Our strengths are the deep understanding of your lab processes, current GxP requirements and a broad and independent knowledge of lab informatics solutions available today and the trends shaping the future lab environment.
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
If you had time for an open discussion with our MyRBQM® Academy instructors, what would you ask Johann, Jo, Linda, or Artem? In our monthly Ask the Expert webinars, we give you that chance. These webinars will focus on trending topics in the area of risk-based quality management (RBQM) - like remote and adaptive monitoring, centralized statistical monitoring, change management, predictive analytics... and more.
Besides a 20-minute Q&A session, our industry experts Jo Burmester and Dr Johann Proeve will dive into:
- How things might change while going forward post-COVID-19
- Statistical guidance for trials impacted by COVID-19
Learn more about MyRBQM Academy here: https://cyntegrity.com/myrbqm-academy/
In the course of any clinical trial, there are risks associated with specific activities and tasks. This webinar will highlight some of these key risk areas and provide guidance on combining technology with best practices to help mitigate risks.
Suddenly the risk-reward balance has shifted dramatically. Anyone with basic cold symptoms is being advised to stay home. And many people can no longer travel with COVID-19 in their community.
What if you can no longer visit your sites? Are you ready to use the tools at your disposal as contingency or risk-mitigation strategies to keep your studies going and ensure your patients can access their study medication and remain safely monitored?
During this virtual discussion forum were putting our minds together to combat the impact of the Coronavirus outbreak on clinical trials, and be better prepared in the future.
We have a unique profile for a CRO providing distinctive and innovative dual expertise by combining clinical research implementation with the development of customized IT applications specific to the pharmaceutical industry.
The FDA Guidance of a Risk-Based Approach to Monitoring as Viewed By CDMwww.datatrak.com
Historical Perspectives in CDM
Overview of the Draft Guidance
A Risked-Based Approach
Challenges to a Risk-Based Approach
Supporting a Risked-Based Approach
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
IDSC is an interdisciplinary group of 40 ex-pharma leaders averaging 25-years of big-pharma, biotech, and academic experience. Our clients come to us for drug discovery and drug development interim leadership, consulting, fully integrated collaborations, due diligence, molecular modeling, and outsourcing management. Because we are a fully integrated drug discovery, preclinical development, and clinical development partner, we help our biotech, VC, academic, and pharma clients get from early discovery to IND filing and through phase I clinical trials in all major therapeutic areas and on to NDA in antibacterials, CNS, and oncology.
This Risk Based Monitoring - Impact on Sites overview presentation, on targeted topics, was delivered to the ACRP Raleigh - Durham Chapter's Annual Conference in 2013.
Strategic Consulting Partners in Life Science for a High Performing Paperless Lab
- Do you need to increase productivity and effectiveness of your lab operations?
- Do you want to reduce time to market and boost collaboration ?
- Are you concerned about data quality / data integrity issues?
- Do you need to replace your lab informatics systems and feel overwhelmed by the complexity of the market?
- Do you need to align consistent processes throughout the organisation?
With our success-proven seven-step program we have realized up to 30% efficiency improvements for major European Life Science companies lab operations.
We are lab-experienced chemists with a solid background in business administration and management, a passion for sustainable process improvements and in-depth knowledge of lab informatics. Originating from the renowned "Vialis paperless lab solutions" team, PEPR-Consulting continues its tradition of successful strategic management consulting for the life science industry.
Our strengths are the deep understanding of your lab processes, current GxP requirements and a broad and independent knowledge of lab informatics solutions available today and the trends shaping the future lab environment.
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
If you had time for an open discussion with our MyRBQM® Academy instructors, what would you ask Johann, Jo, Linda, or Artem? In our monthly Ask the Expert webinars, we give you that chance. These webinars will focus on trending topics in the area of risk-based quality management (RBQM) - like remote and adaptive monitoring, centralized statistical monitoring, change management, predictive analytics... and more.
Besides a 20-minute Q&A session, our industry experts Jo Burmester and Dr Johann Proeve will dive into:
- How things might change while going forward post-COVID-19
- Statistical guidance for trials impacted by COVID-19
Learn more about MyRBQM Academy here: https://cyntegrity.com/myrbqm-academy/
In the course of any clinical trial, there are risks associated with specific activities and tasks. This webinar will highlight some of these key risk areas and provide guidance on combining technology with best practices to help mitigate risks.
Suddenly the risk-reward balance has shifted dramatically. Anyone with basic cold symptoms is being advised to stay home. And many people can no longer travel with COVID-19 in their community.
What if you can no longer visit your sites? Are you ready to use the tools at your disposal as contingency or risk-mitigation strategies to keep your studies going and ensure your patients can access their study medication and remain safely monitored?
During this virtual discussion forum were putting our minds together to combat the impact of the Coronavirus outbreak on clinical trials, and be better prepared in the future.
We have a unique profile for a CRO providing distinctive and innovative dual expertise by combining clinical research implementation with the development of customized IT applications specific to the pharmaceutical industry.
The FDA Guidance of a Risk-Based Approach to Monitoring as Viewed By CDMwww.datatrak.com
Historical Perspectives in CDM
Overview of the Draft Guidance
A Risked-Based Approach
Challenges to a Risk-Based Approach
Supporting a Risked-Based Approach
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
This slideshow is for anyone trying to learn more about the process of hiring a contractor for your home improvements. This slideshow is brought to you by Suburban Windows & Siding of Connecticut.
Service Overview
Site management services to CRO and SITE:
A) Pre initiation
Identification of Potential Sites
Faster Feasibility
Site set up, supplies and other infrastructure needs
Regulatory and IEC/ IRB communications
Rapid negotiation of CTA
Setting up Standard Operating Procedures (SOPs)
B) During Study Duration
Provide dedicated trained and experienced CRCs (Clinical research coordinators)
Patient recruitment & retention Support
Maintenance of essential documents
Source documentation as per ALCOA standards (Attributable, Legible, Contemporaneous, Original & Accurate
Regular IP (Investigational Product) accountability and storage
Completion of CRF’s within timelines
Faster query resolution
Reporting of AE, SAEs within timelines
Support Monitoring visits and Quality Assurance audit action items.
Patient visit Follow Up and compliance assistance
Preparation of site for monitoring and audits/ inspections
C) Post Close out
· Archiving of site results and documents
Site Identification
Faster Feasibility
Ready Sites
Advance Your Program in China with Fully Integrated Clinical Development Solu...Covance
Meet your needs for greater efficiency, expanded capacity and customized support at the newly opened Covance Drug Development Center in Shanghai, China.
Clinical Research Organization Services | Contract Research Company - PepgraPEPGRA Healthcare
Pepgra is a global contract research organization and drug development services company. It provides various phases of clinical research trials services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
Contact Us:
Website : https://bit.ly/33Fwsye
Email us: sales.cro@pepgra.com
India: +91 9884350006
United Kingdom: +44- 74248 10299
Covance Clinical-Biotech: Clinical Trials Designed Around You®Covance
Advance your clinical trial, your way - with a dedicated, flexible approach that's specifically designed for nimble and progressive biotech firms. From specialized expertise on your program team to tailored payment and communication schedules - you'll find unique options to personalize your trial so it works just for you.
2. “Our Belief and Vision define our Success”
Genelife Clinical Research was founded in 2010 with a belief to
succeed in creating a delivery channel which will be able to
reduce the timeline of Drug Development process with highest
possible quality.
Our commitment drives us to carry out the necessary actions to
achieve our objectives successfully. Our aim is to provide the best
service to our clients through the excellence of our work. This
demanding level of professionalism gives belief and security to
our clients.
Quality is base of our growth and to sustain this growth we have
inculcated this as our responsibility of daily work.
Values - Honesty, Morality and Transparency
unbiased and up-front service to our clients and associates.
3. Mission:
To be the preferred partner to our Sponsors in providing complete
solution to product development with unique hallmarks of Quality
and Innovation in the process of integrating and streamlining the
development.
Vision:
To be the most respected partner in providing product
development and unmet clinical research requirements.
Business Goals & Objectives:
To become the world's leading knowledge-driven service provider
for our all Clinical Trial Participants.
“People may forget how fast you did a job –
but they remember how well you did it”
- Famous Quote
4. Genelife is a technologically advanced CRO with experienced
professionals who apply innovative tools and processes to their
clinical development research. We are one of the fastest growing
Contract Research Organization (CRO) providing comprehensive
clinical trials services to the pharmaceutical, biotech, and medical
device industries over a wide range of therapeutic areas. Genelife
is an initiative to provide trust based strategic partnership with
sponsors. Genelife holds to the principle that defensible study
design, reliable data, and thorough analyses are the key
components of a successful product development program.
Genelife’s ability to deliver is demonstrated by the company’s
growth from a small organization to a respected midsize CRO.
Our
APPROACH
5. Services
PLANNING REGULATORY STATISTICAL INPUT
INVESTIGATOR SELECTION MEDICAL WRITING MEDICAL COMMUNITY
ASSESSMENT OPERATION PROJECT EXECUTION
CONTROL REPORTING
QUALITY DATA FAST RECRUITMENT BIGGER MARKET
COST EFFECTIVE LOW RISK
Early Phase Research (Phase I-II)
Genelife Clinical Research believes that a successful trial begins
good site selection to achieve maximum enrollment. Genelife
utilizes experienced project managers and site startup manager
to assist in the recruitment of key investigators for the complex
programs launched in the early phase.
Genelife Clinical Research offers a full range of services for Phase
I-II clinical trials including study design, protocol development,
medical oversight from practicing physicians, site monitoring,
regulatory affairs, database development, biostatistics and data
management.
6. We have developed early phase units within hospitals in India,
Singapore, and Central and East Europe. This provide direct
emergency room access to the subject which is ideal for early
phase study.
Genelife Clinical Research has developed an automated system
for site feasibility and section of early phase clinical trials to select
sites suitable for phase I-II studies.
End Point Studies and Observational Studies
Genelife Clinical Research has extensive experience in Phase III
and Phase IV clinical Trials in different therapeutic areas.
Genelife has conducted/conducting more than 40 global and
domestic clinical trials.
7. Genelife Clinical Research possesses an attitude of difference
with its therapeutic area wise approach for all segments.
We have taken an innovative initiative of developing Theme
Corelab for assisting Clinical Trials with expertise of core-lab in
minimal expenses.
Knowledge Base
Clinical Operations Expertise
Expertise of Investigational tests
Large Data Base of each
Therapeutic area Investigators
Help you determining methodology
for your desired endpoints to
demonstrate safety and performance
, Innovative designs that deliver what
you want Designed customizable
scores and statistical tools
Expertise on Medical out-comes and
their evaluations in reference to the
disease progress and the
investigational product, Inputs in
Designing efficacy and safety trials
Theme core-lab ° is an Expert work
up on theme of a core laboratory for
advanced investigations like
Histopathology, ECG, EEG, Imaging
investigations, mechanical tests
outcomes such as pulmonary function
tests etc. pertaining to respective
therapeutic areas
Disease surveillance reports on
several therapeutic areas Data bases
of many association / societies
8. Project Management is our core competency. We have created an
infrastructure that is based upon some of the most experienced
program and project managers and seasoned investigators who
can smoothly guide any project from the bench to the bedside with
unparalleled speed. Genelife uses Project Managers who have
broad experience in the conduct of complex clinical trials, a key
element to study success. Additionally, we believe, that the Project
Manager’s experience with the therapeutic area being studied is
very important. Our Project Managers are supported by well-
defined, time-tested processes to ensure the completion of study
with limited time and budget.
Project Management
Status, Issues, Results
of process and
project evluations;
measures and analysis
C rr c
e a tio
o e tiv
c
n
What
to monitor
How To Do
How To Do
t
Commitmen s
Project requirements
Technical issues
Completed project components
Acceptance reviews and tests
Plans
Replan
Status, issues
results of
progress and
milestone
review
Corrective
action
SFA -
PP -
PMC -
Site & Study Feasibility Analysis
Project Planning
Project Management And Commissioning
“Effective Project Management is a key element to study success”
9. Genelife has long standing association with few of the esteemed
medical institutes. Genelife has a database of over 900
investigators in all regions of India. These investigators are from
government and private institutions. Considering shrinking
patient population we have identified investigators in tier 2 and 3
cities. Genelife offers unique access and optimal utilization of
opinion leaders, principal investigators, clinics, special subject
populations, regulatory venues, and other trial resources.
Genelife has significant experience in conducting site monitoring.
An onsite monitoring will address regulatory compliance, subject
informed consent, drug accountability, and comparison of
selected CRF data against source documentation.
Clinical Operations
10. Genelife’s Data Management Department dedicates itself to
assuring the integrity of the data generated and its meaningful
interpretation. This is accomplished with rigorous Quality Control.
Genelife follows firm techniques and review procedures to
maintain the integrity of the clinical Trial data. Data management
team speeds the clinical trial process and ensures that data
collection, validation and quality control of data are accurate and
consistent. Our understanding of nCRF and eCRF enables us to
provide the optimum solution for each project. We offer a full range
of EDC services through our own tool using PHP as front end and
MY SQL for database. It is CDISC compliant and can be tailored
to meet all requirements.
Data Management
þ þ
þ þ
þ þ
þ
þ þ
þ
þ
CRF and Database designing Reconciliation of external data
Validation & database validation Discrepancy & Query
specifications Management
Programming & maintain Clinical Data Coding
validation checks Data Quality Control
Data Receipt, Logging, and Data Lock & Database Transfer
Tracking Data Management Reporting
Double Data Entry
11. Genelife Clinical Research offer excellence in SAP writing through
final analysis reporting. The Biostatisticians at who have
extensive experience with ICH E9 as well as analysis and
reporting of clinical trial data. We at Genelife develop the
statistical analysis plan (SAP), design all required tables, listings,
and graphs, and provide final output of all clinical trial data and
final analyses. Our experienced statisticians also provide insight
into the need for expanded analyses in order to clarify a trial’s
outcome with respect to all endpoints evaluated.
For randomization we have developed a computerized central
randomization system that fully validated and 21 CFR, Part 11
compliant. This central Randomization system provide rapid, and
secure access to randomization. This is 24 hour online facility
through which investigators can generate randomization code.
Random
Study Population
Treatment
Control
12. Medical Writing
Genelife Clinical Research provides qualitative medical writing
service for Clinical Trials. Our medical writing team has wide
experience in writing Protocol writing and Clinical study report of
complex drugs. Our reports and Protocols have been excepted by
all regulatory bodies.
With extensive experience, we provide medical writing services as
a whole or at any stage of medical writing.
We have also hired services of some global consultant of study
designing.
þ þ
þ þ
þ þ
þ þ
þ þ
þ þ
Manuscripts Protocol, Investigator
Slide Kits Brochure Financial Disclosure
Posters Patient narratives
CTR Summary Abstracts
CSR Informed consents
Annual Safety Reports Risk profile
13. Genelife’s Medical Safety department offers preparation, review,
approval and reporting of all SAEs reported along with tailored
risk-management strategies across all stages of Product
Development consistent with the requirements of applicable
regulatory bodies.
Pharmacovigilance
þAE and SAE logging, tracking, þPeriodic safety updates
coding as per MeDRA/WHOdrug þSafety analysis and benefit-risk
þSafety/Medical monitoring evaluation
þMedical review of data listings þClinical safety reports
þReview of medical coding data
þPreparation of CTD Module II
þIndividual case safety reports
þExpedited reporting of SAEs
Our Regulatory Department deals with Regulatory Submissions
in and outside India to get necessary clearance from regulatory
bodies for the Study. We have collaborators and consultants who
are able to get faster clearance from any regulatory body.
Regulatory Affairs
14. è
è
è
è
è
è
Technologically advanced CRO
Time bound completion of Project
Fast recruitment
Large investigator pool
Allows sponsor to view real-time project development
Global Operations
USPs
èTransparent and technologically advanced Service
# EDC
# eDocumentation Control System
# Project Management Software
# Central Randomization Software
èBetter Risk Assessment & Management Skill
èSource Data Verification 100%
èExtensive experience working alongside other CROs and understand the
challenges that sometimes arise with multi-CRO integration.
èGlobal Presence
Salient features
16. Asia
12, Ground Floor, Evershine Mall, Chincholi Bunder,
Malad(W), Mumbai-400064, Maharashtra. India
Telephone:+91-22-65242555/67083284
USA
4010 Moorpark Avenue,
Suite 226, San Jose, CA 95117
Telephone: +1-866-994-3121
UK
12, Enterprise Place, 175,
Church Street East, Working, Surrey,
UK GU216AD | Telephone: +44-7424335288
Europe
Dr. Amal k. Mukhopadhyay, Elbgaustrasse 71,
22523 Hamburg Germany
Telephone: +49-163-3243522
www.genelifecr.com